Actinogen Medical

Actinogen Medical Financial Leverage

The Financial Leverage (Equity Multiplier) of Actinogen Medical (ACW.AX) as of Oct 17, 2026 is 1.38. In the previous year, Financial Leverage (Equity Multiplier) was 1.34 — a change of 3.57% (higher).

Financial Leverage

1.38

YoY

3.57%

Last updated:

Financial Leverage (Equity Multiplier) of Actinogen Medical is 2026 1.38 . Financial Leverage (Equity Multiplier) of Actinogen Medical was 2025 1.34 . It decreases by 3.57% higher compared to the previous year.

The Actinogen Medical Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2019
1.04 AUD
Jan 1, 2020
1.10 AUD
Jan 1, 2021
1.05 AUD
Jan 1, 2022
1.07 AUD
Jan 1, 2023
1.13 AUD
Jan 1, 2024
1.08 AUD
Jan 1, 2025
1.34 AUD
Jan 1, 2026
1.38 AUD
The Actinogen Medical Financial Leverage history
YEARFinancial LeverageYoY
1.38+3.57%
1.34+23.39%
1.08-4.62%
1.13+5.81%
1.07+1.84%
1.05-3.97%
1.10+5.86%
1.04-0.86%
1.04-4.19%
1.09+2.08%
1.07+5.27%
1.01-2.56%
1.04—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Actinogen Medical Stock analysis

What does Actinogen Medical do? Actinogen Medical Ltd, based in Sydney, Australia, is a clinical-stage biotechnology company operating in the Health Care sector. It focuses on developing novel treatments for cognitive impairment linked to neurological, psychiatric, and metabolic diseases caused by elevated cortisol levels. The company's lead compound, Xanamem, targets the 11B-HSD1 enzyme in the brain to reduce cortisol, with ongoing Phase II studies for Alzheimer’s Disease, Major Depressive Disorder, and Fragile X Syndrome. The firm has conducted research involving approximately 300 volunteers and patients. Actinogen Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Actinogen Medical stock

Financial Leverage (Equity Multiplier) of Actinogen Medical is 1.38 in 2026.

Financial Leverage (Equity Multiplier) of Actinogen Medical changed from 1.34 to 1.38, representing a 3.57% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Actinogen Medical since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Actinogen Medical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Actinogen Medical

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Actinogen Medical